The “sole purpose” test has interfered with the application of PSQIA principles for well over a decade. It was born when some courts decided that the PSQIA could only protect information generated for the sole purpose of reporting it to a PSO. HHS then incorporated it into nonbinding “guidance” in 2016. This requirement is not in the statute or the rule, but it took on a life of its own, and PSOs have been fighting it in court ever since.
In May, the US Court of Appeals for the 11th Circuit closed the book on the sole purpose test for PSWP. That circuit includes Florida, which is the source of much of the bad case law on the issue.[1] In this employment discrimination case, the plaintiff sought discovery of two classes of peer review documents created and maintained in the hospital’s PSES. The hospital also used the information for internal safety analysis and peer review. The trial court held that the information in dispute was not used for the “sole purpose” of reporting to the PSO and refused to recognize the PSQIA privilege. Defendant BayCare appealed.
From the appellate court opinion:
We agree with BayCare. Under the plain text [emphasis added] of this statute, it does not matter whether BayCare created, used, or maintained the disputed documents for multiple purposes. …[N]owhere does the statute require that privileged information be “kept solely for provision to a Patient Safety Organization. Instead, the Act privileges work product so long as it “identif[ies] or constitute[s] the deliberations or analysis of, or identifies the fact of reporting pursuant to a “patient safety evaluation system.” [42 USC] Section 299b-21(7)(A), regardless of whether it is reported to a patient safety organization. The relevant administrative rule confirms as much. BayCare “may use patient safety work product for any purpose within [its] legal entity.” Patient Safety and Quality Improvement, 72 Fed. Reg. 70732-01 at 70779 (Nov. 21, 2008).
Recognizing the benefit of using the information for other purposes, the court further noted, “Nothing prohibit[s] the disclosure of patient safety work product among physicians and other health care professionals, particularly for educational purposes or for preventing or ameliorating harm.” Id. at 70778. This language clearly allows the use of PSWP outside the boundaries of the organization’s PSES.
The court reviews HHS’s unfortunate 2016 supplemental guidance that seems to incorporate the sole purpose test and finds it to be legally unsound and in clear opposition to the explicit language of the Final Regulation, cited above.
While this opinion is great news, defendants relying on the PSQIA must use diligence in defending the privilege. Defense counsel representing PSO participants must still diligently present their arguments supporting the privilege. We continue to offer these recommendations:
https://blog.centerforpatientsafety.org/part-1-attorney-client-privilege-psqia
[1] In Re: BayCare Medical Group, No. 23-12571, May 14, 2024. Download a copy of the opinion here.